✦ LIBER ✦

Lung cancer: OPTIMAL results for erlotinib in NSCLC

✍ Scribed by Hutchinson, Lisa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib treatment results in patients

✍ Salajka, F.; Pešek, M.; Skřičková, J.; Zatloukal, P.; Koubková, L.; Grygárková, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

PCN67 Erlotinib as Second Line Treatment

✍ Santos, E.A.V.; Buschinelli, C.T.; Ferracini, M.; Pepe, C.; Estanislao, M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Erlotinib approved in Switzerland for NS

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

9151 Treatment of patients with advanced

✍ Faehling, M.; Eckert, R.; Kuom, S.; Kamp, T.; Stoiber, K.; Kropf, C.; Rüdiger, S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

23 Experience of erlotinib for non-small

✍ Minear, F.G.; Ward, A.J.; Dorey, N.E.; Osborne, M.E.; Toy, E.W. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 35 KB

130PD ERLOTINIB RELATED TOXICITY IN ELDE

✍ Palazzo, A.; Iacovelli, R.; Mazzoli, M.; Mancini, M.L.; Passaro, A.; Altavilla, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB